A Randomized Phase II Study Evaluating the Food Effect on the Pharmacokinetics and Pharmacodynamics of Abiraterone Acetate in Men With Castration Resistant Prostate Cancer
Phase of Trial: Phase II
Latest Information Update: 28 Mar 2018
At a glance
- Drugs Abiraterone acetate (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 28 Mar 2018 Status changed from active, no longer recruiting to completed, according to the results published in the Journal of Clinical Oncology.
- 28 Mar 2018 Results published in the Journal of Clinical Oncology.
- 19 Jun 2017 Planned End Date changed from 1 May 2017 to 1 Dec 2017.